Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants

@inproceedings{Wu2008ComparisonOT,
  title={Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants},
  author={Eric Qiong Wu and Paul B Greenberg and Elaine Yang and Andrew Peng Yu and Rym Ben-Hamadi and M. Haim Erder},
  year={2008}
}
ABSTRACTObjective: To assess treatment persistence, hospitalization outcomes and mean healthcare costs of geriatric major depressive disorder (MDD) patients treated with escitalopram compared to other selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs).Research design and methods: Patients aged ≥ 65 years with at least one inpatient claim or two independent claims associated with MDD diagnosis were identified in the IHCIS National Managed… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

Functional neuroimaging in geriatric depression.

  • The Psychiatric clinics of North America
  • 2011
VIEW 1 EXCERPT
CITES BACKGROUND

The relationship between the acute cerebral metabolic response to citalopram and chronic citalopram treatment outcome.

  • The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
  • 2011